[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 18, Issue 3 (jrds 2021) ::
J Res Dent Sci 2021, 18(3): 228-240 Back to browse issues page
Management of Xerostomia in Covid-19 patints: A review article
Mehrnoosh Meshkat sadat , Arezoo Alaee , Somayeh Alirezaei
, Arezoo.alaee@yahoo.com
Abstract:   (25460 Views)
Abstract
Background and Aim: Xerostomia, is a chronic and common symptom of dry mouth that many patients report when they meet their doctor or dentist or oral hygienist. As far as Corona virus spreading widely, it is khown as one of the latest etiology for this complication. Salivary reduction causes serious damages to the oral and pharyngeal mucosa due to dryness, Same as oral and pharyngeal mucosa discontinuity. The aim of this study was to evaluate dry mouth and its necessary treatment considerations in related articles in  patients with Covid19, as important and know complicate.
Material and Methods: by searching the keywords, COVID-19; Therapeutics; Xerostomia; Salivary glands in data bases such as pubmed; Google scholar; scopus; SID; net,  40 articles that published between the years 2016-2020, which are conformed with our inclusive and exclusive factors ,were selected.
Results: Secondary to taste dysfunction (59.5%), Xerostomia (45.9%) is the most prevalent condition related to corona infection. 74.5% of corona infected who experience Xerostomia, announced that they have had the signs of Xerostomia before covid-19 diagnosis. Some medications used in the treatment of Covid-19, such as antiviral drugs (Remdesivir and Ritonavir) and antimuscarinic drugs, also causes dry mouth. There is a wide range and different efficiencies of dry mouth treatments. The new emerged therapies have also been effective in treating dry mouth and have shown promising results.
Conclusion: The corona virus can affected salivary glands function, directly and indirectly. It cause changes in amount and quality of saliva, the important and significant result of which is dry mouth. It could be secondary to the destructive activity of the virus, or secondary to the use of therapeutic drugs. Due to the widespread effects of dry mouth on patients' quality of life, It is important to consider concomitant treatment of dry mouth in patients who affected by covid-19 currently or in past.
Keywords: SARS-CoV-2/COVID-19, Dentistry, xerostomia, dry mouth, therapeutics
Full-Text [PDF 353 kb]   (4182 Downloads)    
Type of Study: Review article | Subject: Oral Medicine
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

meshkat sadat M, alaee A, Alirezaei S. Management of Xerostomia in Covid-19 patints: A review article. J Res Dent Sci. 2021; 18 (3) :228-240
URL: http://jrds.ir/article-1-1208-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 18, Issue 3 (jrds 2021) Back to browse issues page
مجله تحقیق در علوم دندانپزشکی Res Dent Sci
Persian site map - English site map - Created in 0.05 seconds with 29 queries by YEKTAWEB 4410